Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection

Virology Journal

Volumn 15, Issue 1, 2018, Pages

  Kikuti, Mariana ^a,b   Tauro, Laura B ^a,c   Moreira, Patrícia S S ^a   Campos, Gúbio S ^b   Paploski, Igor A D ^a,b   Weaver, Scott C ^d   Reis, Mitermayer G ^a,b   Kitron, Uriel ^a,e   Ribeiro, Guilherme S ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Instituto Nacional de Medicina Tropical CONICET ^*  (Argentina)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

Enzyme linked immunosorbent assay; Immunoglobulin G; Immunoglobulin M; Sensitivity and specificity; Zika virus

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; DENGUE; DIAGNOSTIC VALUE; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; ZIKA FEVER; ZIKA VIRUS; GENETICS; IMMUNOLOGY; REPRODUCIBILITY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; YOUNG ADULT; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85049982621     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/s12985-018-1015-6     Document Type: Article

References (25)

1. Duffy MR, Chen T-H, Hancock WT, Powers AM, Kool JL, Lanciotti RS, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med. 2009;360:2536-43.
2. Musso D, Gubler DJ. Zika Virus. Clin Microbiol Rev [Internet]. 2016;29:487-524. Available from: http://cmr.asm.org/content/29/3/487.
3. Cardoso CW, Paploski IAD, Kikuti M, Rodrigues MS, Silva MMO, Campos GS, et al. Outbreak of Exanthematous Illness Associated with Zika, Chikungunya, and Dengue Viruses, Salvador, Brazil. Emerg Infect Dis J [Internet]. 2015;21:2274-6. Available from: http://wwwnc.cdc.gov/eid/article/21/12/15-1167
4. Paploski IAD, Prates APPB, Cardoso CW, Kikuti M, Silva MMO, Waller LA, et al. Time Lags between Exanthematous Illness Attributed to Zika Virus, Guillain-Barré Syndrome, and Microcephaly, Salvador, Brazil. Emerg Infect Dis J [Internet]. 2016;22 Available from: http://wwwnc.cdc.gov/eid/article/22/8/16-0496
5. Cao-Lormeau V-M, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet Elsevier. 2016;387:1531-9.
6. Musso D, Rouault E, Teissier A, Lanteri MC, Zisou K, Broult J, et al. Molecular detection of Zika virus in blood and RNA load determination during the French Polynesian outbreak. J Med Virol [Internet]. 2016;9999:1-6. Available from: http://dx.doi.org/10.1002/jmv.24735
7. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, yap state, Micronesia, 2007. Emerg Infect Dis. 2008;14:1232-9.
8. Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-Spaeth G, Duangchinda T, et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol [Internet]. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.; 2016;17:1102-8. Available from: https://doi.org/10.1038/ni.3515
9. Felix AC, Souza NCS, Figueiredo WM, Costa AA, Inenami M, da Silva RMG, et al. Cross reactivity of commercial anti-dengue immunoassays in patients with acute Zika virus infection. J Med Virol [Internet]. 2017;89:1477-1479. Available from: https://doi.org/10.1002/jmv.24789
10. Priyamvada L, Quicke KM, Hudson WH, Onlamoon N, Sewatanon J, Edupuganti S, et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci [Internet]. 2016;113:7852-7. Available from: http://www.pnas.org/content/113/28/7852.
11. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ [Internet]. 2015;351:h5527. Available from: https://www.bmj.com/content/351/bmj.h5527.long.
12. Teixeira M da G, Costa M da CN, Barreto ML, Barreto FR. Epidemiologia do dengue em Salvador-Bahia,1995-1999. Rev Soc Bras Med Trop [Internet]. 2001;34:269-274. Available from: https://doi.org/10.1590/S0037-86822001000300007.
13. BRASIL. Dengue: Notificações registradas no Sistema de Informação de Agravos de Notificação - SINAN, Brazil. [Internet]. 2017 [cited 2017 Oct 24]. Available from: http://www.tabnet.saude.salvador.ba.gov.br/tabcgi.exe?sinan-online/dengueneton.def
14. Silva MMO, Rodrigues MS, Paploski IAD, Kikuti M, Kasper AM, Cruz JS, et al. Accuracy of Dengue Reporting by National Surveillance System, Brazil. Emerg Infect Dis J [Internet]. 2016;22:336. Available from: http://wwwnc.cdc.gov/eid/article/22/2/15-0495
15. Kikuti M, Cunha GM, Paploski I a. D, Kasper AM, Silva MMO, Tavares AS, et al. Spatial distribution of dengue in a Brazilian urban slum setting: role of socioeconomic gradient in disease risk. PLoS Negl Trop Dis [Internet]. 2015;9:e0003937. Available from: http://dx.plos.org/10.1371/journal.pntd.0003937
16. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol [Internet]. 1992/03/01 ed. 1992;30:545-51. Available from: http://jcm.asm.org/content/30/3/545.long.
17. Balm MND, Lee CK, Lee HK, Chiu L, Koay ESC, Tang JW. A diagnostic polymerase chain reaction assay for Zika virus J Med Virol [Internet]. 2012;84:1501-1505. Available from: http://doi.wiley.com/10.1002/jmv.23241
18. Edwards CJ, Welch SR, Chamberlain J, Hewson R, Tolley H, Cane PA, et al. Molecular diagnosis and analysis of Chikungunya virus. J Clin Virol [Internet]. 2007;39:271-275. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1386653207001850
19. Steinhagen K, Probst C, Radzimski C, Emmerich P, Van EM, Schinkel J, et al. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016. Euro Surveill. 2016;21:30426.
20. Van EM, Meersman K, Michiels J, Ariën KK, Van Den BD. Letter to the editor: specificity of Zika virus ELISA: interference with malaria. Euro Surveill. 2016;21:3-4.
21. Huzly D, Hanselmann I, Panning M. High specificity of a novel Zika virus ELISA in European patients after exposure to different flaviviruses. Euro Surveill. 2016;21:1-4.
22. Lustig Y, Zelena H, Venturi G, Van Esbroeck M, Rothe C, Perret C, et al. Sensitivity and Kinetics of an NS1-Based Zika Virus Enzyme-Linked Immunosorbent Assay in Zika Virus-Infected Travelers from Israel, the Czech Republic, Italy, Belgium, Germany, and Chile. J Clin Microbiol [Internet]. 2017;55:1894-901. Available from: http://jcm.asm.org/content/55/6/1894.
23. Faria NR, Azevedo R d. S d. S, Kraemer MUG, Souza R, Cunha MS, Hill SC, et al. Zika virus in Americas: Early epidemiological and genetic findings. Science (80-) [Internet]. 2016;352:345-9. Available from: http://www.sciencemag.org/cgi/doi/10.1126/science.aaf5036
24. Ayllón T, Campos R de M, Brasil P, Morone FC, Câmara DCP, Meira GLS, et al. Early Evidence for Zika Virus Circulation among Aedes aegypti Mosquitoes, Rio de Janeiro, Brazil. Emerg Infect Dis J [Internet]. 2017;23:1411. Available from: http://wwwnc.cdc.gov/eid/article/23/8/16-2007
25. Passos SRL, Santos MAB dos, Cerbino-Neto J, Buonora SN, Souza TML, Oliveira RVC de, et al. Detection of Zika Virus in April 2013 Patient Samples, Rio de Janeiro, Brazil. Emerg Infect Dis J [Internet]. 2017;23:2120. Available from: http://wwwnc.cdc.gov/eid/article/23/12/17-1375